Engineering a future where biologic medicines are swallowed, not injected.

Engineering a future where biologic medicines are swallowed, not injected.

CapsulateBio is pioneering robotic oral drug delivery systems that transform injectable biologics into oral medicines, unlocking a new era for patients, physicians, and pharmaceutical innovators.

CapsulateBio is pioneering robotic oral drug delivery systems that transform injectable biologics into oral medicines, unlocking a new era for patients, physicians, and pharmaceutical innovators.

See CapsulateSI™ platform in action

See CapsulateSI™ platform in action

From ingestion to systemic absorption, experience the precision engineering behind next-generation oral biologic delivery.

How CapsulateSI™ works

How CapsulateSI™ works

How CapsulateSI™ works

(01)

Swallow capsule

Patient takes an easy-to-swallow capsule, the size of many common medicine capsules.

person swallowing the pill

(01)

Swallow capsule

Patient takes an easy-to-swallow capsule, the size of many common medicine capsules.

person swallowing the pill

(01)

Swallow capsule

Patient takes an easy-to-swallow capsule, the size of many common medicine capsules.

person swallowing the pill

(02)

Pass through GI tract

Once swallowed, the capsule carries the biologic drug material safely through the stomach to the small intestine.

(02)

Pass through GI tract

Once swallowed, the capsule carries the biologic drug material safely through the stomach to the small intestine.

(02)

Pass through GI tract

Once swallowed, the capsule carries the biologic drug material safely through the stomach to the small intestine.

(03)

Deliver drug material

In the small intestine, the capsule activates and delivers liquid drug material into the intestinal wall, achieving bioavailability comparable to a subcutaneous injection.

(03)

Deliver drug material

In the small intestine, the capsule activates and delivers liquid drug material into the intestinal wall, achieving bioavailability comparable to a subcutaneous injection.

(03)

Deliver drug material

In the small intestine, the capsule activates and delivers liquid drug material into the intestinal wall, achieving bioavailability comparable to a subcutaneous injection.

(04)

Pass device capsule

Once the drug material has been delivered, the capsule passes naturally through the body.

(04)

Pass device capsule

Once the drug material has been delivered, the capsule passes naturally through the body.

(04)

Pass device capsule

Once the drug material has been delivered, the capsule passes naturally through the body.

How CapsulateST™ works

How CapsulateST™ works

How CapsulateST™ works

(01)

Swallow capsule

Patient takes an easy-to-swallow capsule, the size of a small blueberry.

3D model of a character

(01)

Swallow capsule

Patient takes an easy-to-swallow capsule, the size of a small blueberry.

3D model of a character

(02)

Pass through GI tract

The capsule carries the biologic drug material safely through to the stomach.

(02)

Pass through GI tract

The capsule carries the biologic drug material safely through to the stomach.

(03)

Deliver drug material

In the stomach, the capsule activates and delivers solid drug material into the stomach wall, achieving bioavailability comparable to a subcutaneous injection.

(03)

Deliver drug material

In the stomach, the capsule activates and delivers solid drug material into the stomach wall, achieving bioavailability comparable to a subcutaneous injection.

(04)

Pass device capsule

Once the drug material has been delivered, the capsule passes naturally through the body.

(04)

Pass device capsule

Once the drug material has been delivered, the capsule passes naturally through the body.

Delivering biologics over 1,000× larger than conventional oral therapies

Delivering biologics over 1,000× larger than conventional oral therapies

Where conventional oral technologies are limited to the delivery of small molecules and peptides, CapsulateBio's technology can deliver all therapeutic modalities.

Diagram of six molecules progressively increasing in size from <1 kDa to 1500+ kDa
Diagram of six molecules progressively increasing in size from <1 kDa to 1500+ kDa

Partner on the next generation of biologics

CapsulateBio is actively pursuing strategic collaborations with leading biopharmaceutical companies to unlock the full potential of biologics across a broad range of therapeutic areas through our CapsulateSI™ oral delivery platforms.

Partner on the next generation of biologics

CapsulateBio is actively pursuing strategic collaborations with leading biopharmaceutical companies to unlock the full potential of biologics across a broad range of therapeutic areas through our CapsulateSI™ oral delivery platforms.

Partner on the next generation of biologics

CapsulateBio is actively pursuing strategic collaborations with leading biopharmaceutical companies to unlock the full potential of biologics across a broad range of therapeutic areas through our CapsulateSI™ oral delivery platforms.

Partner on the next generation of biologics

CapsulateBio is actively pursuing strategic collaborations with leading biopharmaceutical companies to unlock the full potential of biologics across a broad range of therapeutic areas through our CapsulateSI™ oral delivery platforms.

Reinventing injection with a pill

© 2026 CapsulateBio

™

Reinventing injection with a pill

™

© 2026 CapsulateBio

™

Reinventing injection with a pill

© 2026 CapsulateBio

™

CapsulateBio